In the abnormal copy number additive model, MDM2 CNVs are significantly associated with increased CRC risk (del + amp v.s. wt: ORadjusted = 6.35, 95% CI: 1.67, 24.19, P = 0.007). This evidence concerns the gene MDM2 and colorectal carcinoma.